Bart J. van Vlijmen - Concepedia

Author

Bart J. van Vlijmen

Also Known As

B J van Vlijmen, Bart J van Vlijmen, Bart J. Van Vlijmen, Bart J. van Vlijmen, Bart J.M van Vlijmen, Bart JM van Vlijmen

Publications

621

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center McGill University Genome British Columbia Netherlands Organisation for Applied Scientific Research Leiden University

About

Bart J. van Vlijmen is an author at Leiden University Medical Center specializing in medicine, vascular biology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	393
2	Health Sciences	3	3	373
3	Biochemistry	2	2	281
4	Cell Biology	2	2	112
5	Epidemiology	1	1	92

Bart J. van Vlijmen

Publications

617

Citations

H-Index

Page 1

	Year	Citations
Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. Bart J. van Vlijmen, Arn M. J. M. van den Maagdenberg, Marion J. Gijbels, Journal of Clinical Investigation NutritionApolipoprotein E3-leidenDiet-induced HyperlipoproteinemiaHyperlipidemiaHfc Diets	1994	250
Macrophage LRP1 contributes to the clearance of von Willebrand factor Ghasem Rastegarlari, Julie Pegon, Caterina Casari, Blood	2012	120
Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice. Bart J. van Vlijmen, H. Belinda van 't Hof, M.J.T.M. Mol, Journal of Clinical Investigation Apolipoprotein E3-leidenGeneticsHyperlipidemiaOxidative StressMetabolic Syndrome	1996	92
Key Role of Platelet Procoagulant Activity in Tissue Factor‐and Collagen‐Dependent Thrombus Formation in Arterioles and Venules <i>In Vivo</i> Differential Sensitivity to Thrombin Inhibition Marijke J. E. Kuijpers, Imke C.A. Munnix, Judith M.E.M. Cosemans, Microcirculation	2008	65
Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs. Bart J. van Vlijmen, Neil Pearce, Martin O. Bergö, PubMed Test ModelGenetic EpidemiologyPathologyHyperlipidemiaPlasma Cholesterol	1998	31
Multiplexed targeted proteomic assay to assess coagulation factor concentrations and thrombosis-associated cancer Yassene Mohammed, Bart J. van Vlijmen, Juncong Yang, Blood Advances	2017	25
Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP) A. Seda Yilmaz‐Elis, Annemieke Aartsma‐Rus, Peter A.C. ’t Hoen, Molecular Therapy — Nucleic Acids Il-1 SignalingSoluble δ9Il-1racp ProteinInflammatory Lung DiseaseImmunologyImmune Regulation	2013	20
Targeted proteomics for evaluating risk of venous thrombosis following traumatic lower‐leg injury or knee arthroscopy Yassene Mohammed, Carolina E. Touw, Banne Nemeth, Journal of Thrombosis and Haemostasis	2021	14

Page 1